1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine < 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine (administration & dosage)

Facettes :

List of bibliographic references

Number of relevant bibliographic references: 36.
[0-20] [0 - 20][0 - 36][20-35][20-40]

Ident.	Authors (with country if any)	Title
000095 (2000)	F. Calon [Canada] ; M. Morissette ; M. Goulet ; R. Grondin ; P J Blanchet ; P J Bédard ; T. Di Paolo	125I-CGP 64213 binding to GABA(B) receptors in the brain of monkeys: effect of MPTP and dopaminomimetic treatments.
000155 (2001)	F. Calon [Canada] ; N. Lavertu ; A M Lemieux ; M. Morissette ; M. Goulet ; R. Grondin ; P J Blanchet ; P J Bédard ; T. Di Paolo	Effect of MPTP-induced denervation on basal ganglia GABA(B) receptors: correlation with dopamine concentrations and dopamine transporter.
000306 (2003)	Nancy Bélanger [Canada] ; Laurent Grégoire ; Paul Bédard ; Thérèse Di Paolo	Estradiol and dehydroepiandrosterone potentiate levodopa-induced locomotor activity in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine monkeys.
000332 (1992)	B. Gomez-Mancilla [Canada] ; R. Boucher ; P J Bédard	Effect of LY 171555 and CY 208-243 on tremor suppression in the MPTP monkey model of parkinsonism.
000336 (1992)	B. Gomez-Mancilla [Canada] ; J F Latulippe ; R. Boucher ; P J Bédard	Effect of ethosuximide on rest tremor in the MPTP monkey model.
000361 (2003)	Pershia Samadi [Canada] ; Laurent Grégoire ; Paul J. Bédard	Opioid antagonists increase the dyskinetic response to dopaminergic agents in parkinsonian monkeys: interaction between dopamine and opioid systems.
000463 (1992)	B. Gomez-Mancilla [Canada] ; P J Bédard	Effect of estrogen and progesterone on L-dopa induced dyskinesia in MPTP-treated monkeys.
000596 (2006)	J. Miklossy [Canada] ; D D Doudet ; C. Schwab ; S. Yu ; E G Mcgeer ; P L Mcgeer	Role of ICAM-1 in persisting inflammation in Parkinson disease and MPTP monkeys.
000628 (2006)	Jordi Gomez-Ramirez [Canada] ; Tom H. Johnston ; Naomi P. Visanji ; Susan H. Fox ; Jonathan M. Brotchie	Histamine H3 receptor agonists reduce L-dopa-induced chorea, but not dystonia, in the MPTP-lesioned nonhuman primate model of Parkinson's disease.
000647 (2006)	Marc Morissette [Canada] ; Mehdi Dridi ; Frédéric Calon ; Abdallah Hadj Tahar ; Leonard T. Meltzer ; Paul J. Bédard ; Thérèse Di Paolo	Prevention of dyskinesia by an NMDA receptor antagonist in MPTP monkeys: effect on adenosine A2A receptors.
000660 (1991)	B. Lavoie [Canada] ; A. Parent	Dopaminergic neurons expressing calbindin in normal and parkinsonian monkeys.
000662 (1991)	W G Tatton [Canada] ; C E Greenwood	Rescue of dying neurons: a new action for deprenyl in MPTP parkinsonism.
000916 (2008)	Marc Morissette [Canada] ; Sara Al Sweidi ; Sophie Callier ; Thérèse Di Paolo	Estrogen and SERM neuroprotection in animal models of Parkinson's disease.
000A16 (1991)	B. Gomez-Mancilla [Canada] ; R. Boucher ; P J Bédard	Effect of clonidine and atropine on rest tremor in the MPTP monkey model of parkinsonism.
001077 (2012)	Mélanie Bourque [Canada] ; Dean E. Dluzen ; Thérèse Di Paolo	Signaling pathways mediating the neuroprotective effects of sex steroids and SERMs in Parkinson's disease.
001742 (2014)	Marianna Sikorska [Canada] ; Patricia Lanthier [Canada] ; Harvey Miller [Canada] ; Melissa Beyers [Canada] ; Caroline Sodja [Canada] ; Bogdan Zurakowski [Canada] ; Sandhya Gangaraju [Canada] ; Siyaram Pandey [Canada] ; Jagdeep K. Sandhu [Canada]	Nanomicellar formulation of coenzyme Q10 (Ubisol-Q10) effectively blocks ongoing neurodegeneration in the mouse 1-methyl-4- phenyl-1,2,3,6-tetrahydropyridine model: potential use as an adjuvant treatment in Parkinson’s disease
001978 (2014)	Jean-Francois Poulin ; Jian Zou ; Janelle Drouin-Ouellet [Royaume-Uni] ; Kwang-Youn A. Kim ; Francesca Cicchetti ; Rajeshwar B. Awatramani	Defining midbrain dopaminergic neuron diversity by single-cell gene profiling
001A81 (1989)	P J Bédard [Canada] ; R. Boucher	Effect of D1 receptor stimulation in normal and MPTP monkeys.
001B57 (2015)	Vincent A. Jourdain ; Nicolas Morin ; Laurent Grégoire ; Marc Morissette ; Thérèse Di Paolo	Changes in glutamate receptors in dyskinetic parkinsonian monkeys after unilateral subthalamotomy.
001D48 (2016)	Mohammed Filali [Canada] ; Robert Lalonde [France]	Neurobehavioral Anomalies in the Pitx3/ak Murine Model of Parkinson's Disease and MPTP.
002314 (1988)	P. Falardeau [Canada] ; S. Bouchard ; P J Bédard ; R. Boucher ; T. Di Paolo	Behavioral and biochemical effect of chronic treatment with D-1 and/or D-2 dopamine agonists in MPTP monkeys.

---

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Canada/explor/ParkinsonCanadaV1/Data/Ncbi/Curation

HfdIndexSelect -h $EXPLOR_AREA/Data/Ncbi/Curation/KwdEn.i -k "1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine" 

HfdIndexSelect -h $EXPLOR_AREA/Data/Ncbi/Curation/KwdEn.i  \
                -Sk "1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Ncbi/Curation/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Canada
   |area=    ParkinsonCanadaV1
   |flux=    Ncbi
   |étape=   Curation
   |type=    indexItem
   |index=    KwdEn.i
   |clé=    1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine
}}

---

This area was generated with Dilib version V0.6.29. Data generation: Thu May 4 22:20:19 2017. Site generation: Fri Dec 23 23:17:26 2022